Immune and non-immune functions of the immunoproteasome
- PMID: 22201844
- DOI: 10.2741/4027
Immune and non-immune functions of the immunoproteasome
Abstract
The biological importance of the ubiquitin-proteasome system in the control of myriad cellular processes has been well-recognized; however, the pathophysiological significance of the immunoproteasome, the inducible form of the proteasome, has not been well-comprehended until lately. The primary function of the immunoproteasome was originally believed to improve MHC-I antigen presentation. It now becomes evident that the immunoproteasome possesses broader biological functions. It regulates proinflammatory cytokine production, and T cell differentiation and proliferation. Alongside immune functions, the immunoproteasome has been demonstrated to relieve oxidative stress by the efficient turnover of oxidatively-damaged proteins and by allaying the formation of harmful protein aggregates. Furthermore, it has been implicated to regulate tumor cell growth and control muscle mass. Finally, the immunoproteasome has recently drawn considerable attention as a potential novel therapeutic target for cancer and autoimmune disease. This review will give an overview of the structure and function of the immunoproteasome, highlight its functional diversity in both immune and non-immune responses, and discuss the relationship between the dysregulation of the immunoproteasome and the development of several human diseases.
Similar articles
-
Inhibitors of the immunoproteasome: current status and future directions.Curr Pharm Des. 2013;19(22):4140-51. doi: 10.2174/1381612811319220018. Curr Pharm Des. 2013. PMID: 23181576 Free PMC article. Review.
-
The Immunoproteasome in oxidative stress, aging, and disease.Crit Rev Biochem Mol Biol. 2015 Jul-Aug;51(4):268-81. doi: 10.3109/10409238.2016.1172554. Epub 2016 Apr 20. Crit Rev Biochem Mol Biol. 2015. PMID: 27098648 Free PMC article. Review.
-
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma.Pharmacol Ther. 2018 Feb;182:176-192. doi: 10.1016/j.pharmthera.2017.09.001. Epub 2017 Sep 11. Pharmacol Ther. 2018. PMID: 28911826 Review.
-
On the Role of the Immunoproteasome in Protein Homeostasis.Cells. 2021 Nov 18;10(11):3216. doi: 10.3390/cells10113216. Cells. 2021. PMID: 34831438 Free PMC article. Review.
-
The immunoproteasome in antigen processing and other immunological functions.Curr Opin Immunol. 2013 Feb;25(1):74-80. doi: 10.1016/j.coi.2012.11.004. Epub 2012 Dec 6. Curr Opin Immunol. 2013. PMID: 23219269 Review.
Cited by
-
Inhibitors of the immunoproteasome: current status and future directions.Curr Pharm Des. 2013;19(22):4140-51. doi: 10.2174/1381612811319220018. Curr Pharm Des. 2013. PMID: 23181576 Free PMC article. Review.
-
Expanding proteostasis by membrane trafficking networks.Cold Spring Harb Perspect Biol. 2013 Jul 1;5(7):a013383. doi: 10.1101/cshperspect.a013383. Cold Spring Harb Perspect Biol. 2013. PMID: 23426524 Free PMC article. Review.
-
Gallic Acid Attenuates Angiotensin II-Induced Hypertension and Vascular Dysfunction by Inhibiting the Degradation of Endothelial Nitric Oxide Synthase.Front Pharmacol. 2020 Jul 22;11:1121. doi: 10.3389/fphar.2020.01121. eCollection 2020. Front Pharmacol. 2020. PMID: 32848742 Free PMC article.
-
Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies.Antioxid Redox Signal. 2014 Dec 10;21(17):2322-43. doi: 10.1089/ars.2013.5823. Epub 2014 Oct 1. Antioxid Redox Signal. 2014. PMID: 25133688 Free PMC article. Review.
-
Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice.Front Cell Dev Biol. 2020 Oct 23;8:592048. doi: 10.3389/fcell.2020.592048. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33195259 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
